Objective: Although interagency collaboration in drug treatment and rehabilitation has been substantially studied, a lack of consensus on the nomenclature and definition of collaboration remains an unresolved issue in public health policy and practice. To facilitate further consensus, this review analyses previously used definition, conceptualization, and theorization on interagency collaboration in the field of drug rehabilitation. Methods: We conducted evidence synthesis using a scoping review approach. This review is based on searches using the MEDLINE, CINAHL Complete, Embase, and PsychINFO databases and used the protocol proposed by Arksey and O’Malley. Results: A total of 6,259 papers were retrieved from database and citation searches, 33 of which were eligible for inclusion in the analysis after screening and evaluation. Although the definitions varied, the common elements included (a) the presence of at least two entities, which were either services, programs or organizations; (b) these entities collaborated or shared resources; (c) partnership went through a development process; and (d) the intent of collaboration was to achieve a common purpose. There were five means of conceptualizing collaboration: (a) degrees, or level of intensity and formality; (b) elements, or the constitutive structure and activities; (c) stages, or the development of partnership over time; (d) levels, or the focus of the collaborative; and (e) type, or a distinction between collaboration on in policy and practice. Conclusion Scholarship in this field can benefit from studies that conceptualize collaboration not only crosssectionally through the description of degrees, elements, levels, and type, but also by considering the stages dimension of collaboration (i.e., evolution of collaboration initiative over time). Countries or jurisdictions may need to formalize a term and definition for collaboration as it applies to initiatives within their territories.
Intersectoral collaboration ; review

Vector Borne Diseases ; Intersectoral Collaboration

Background: 'Inter-organizational collaboration' and 'partnership' have been emphasized in drug treatment and rehabilitation over the decades. Nevertheless, the synthesis of knowledge of related arrangements has been limited in scope. This study fills a gap by systematically reviewing the features, outcomes, facilitators, and barriers of inter-organizational collaborations in drug rehabilitation to propose insights to improve policy and practice. Methodology: This review is based on searches of MEDLINE, CINAHL Complete, Embase, and PsychINFO databases. All retrieved papers were independently screened and underwent quality assessment based on the protocol proposed by Peters et al. (2017). Data charting from the included sources was performed using NVivo. Results: A total of 5,631 unique records were retrieved, of which 54 were included in the analysis. Most of the papers were published between 2011 and 2019, and primarily described, or tested, a collaborative activity from a case study or survey research. Treatment services were often partnered with public health, primary care, or social service organizations. The outcomes of initiatives were commonly about the increase in service utilization or the enhancement of service provision. Facilitators and barriers to collaboration were reported by two-thirds of the papers, which primarily pertained to contextual or organizational dimensions. Conclusion This piece of evidence provides good descriptive content on what, how, and how well the interorganizational collaborations have been conducted in drug treatment and rehabilitation. Implications for promoting good practices that range from University education, staff exchange, and incentives to support by governments are discussed.
Intersectoral Collaboration ; Substance-Related Disorders ; Substance Abuse Treatment Centers

Objectives: This scoping review aimed to support a landscape analysis to identify lessons learned about intersectoral collaborations (ISCs) by describing their existing models in the context of dengue, malaria and yellow fever. Methods: A scoping review following the methodology of Joanna Briggs Institute was performed using the following inclusion criteria: studies involving humans; studies discussing intersectoral collaborations, malaria/dengue/yellow fever, and prevention or control at any level; and studies in countries endemic for the aforementioned diseases. Studies were screened using Covidence, while data were extracted using NVivo. Results: Of the 7,535 records retrieved, 69 were included in the qualitative analysis. Most ISCs were initiated by multilateral organizations and ministries of health, and none by communities. Strategies included advocacy, health education, research, public health measures, resource mobilization, service delivery and training; mostly employed on a community level. Monitoring and evaluation were mostly formative, ongoing, and participatory. Gaps included administrative and policy barriers, resource shortages, and inadequate research and training. Conclusions Multiple models of ISC exist in the literature. There is a need to develop a comprehensive framework for an effective and sustainable multisectoral approach for the prevention and control of VBDs ensuring adequate resources, active stakeholders, and strategies that span the entire socio-ecological spectrum.
Dengue ; Disease Vectors ; Intersectoral Collaboration ; Malaria ; Vector Borne Diseases

Traumatic brain injury (TBI) represents a huge global medical and public health problem across all ages and in all populations. In this review, we discussed the changing concepts and approaches. Globally, the incidence is increasing and in high income countries epidemiologic patterns are changing with consequences for prevention campaigns. TBI should not be viewed as an event, but as a progressive and chronic disease with lifetime consequences. In the clinical field, precision approaches to treatment are being developed, which require more accurate disease phenotyping. Recent advances in genomics, neuroimaging and biomarker development offer great opportunities to develop improved phenotyping and better disease characterization. In clinical research, randomized controlled clinical trials are being complemented by large data collections in broad TBI populations in comparative effectiveness designs. Global collaborations are being developed among funding agencies, research organizations and researchers. Only by combining efforts and collaboration will we be able to advance the field by providing long-needed evidence to support practice recommendations and to improve treatment.
Brain Injuries, Traumatic ; epidemiology ; therapy ; Diffusion Tensor Imaging ; Humans ; Intersectoral Collaboration ; Intracranial Pressure

China ; Humans ; Intersectoral Collaboration ; Lung Neoplasms ; diagnosis ; therapy ; Societies, Medical ; Universities

Humans ; Intersectoral Collaboration ; Medicine, Chinese Traditional ; Neoplasms ; drug therapy ; Tumor Microenvironment ; drug effects ; Western World

The treatment of severe trauma, especially multiple injuries, requires multidisciplinary collaboration. The current study aims to highlight the challenges of consultation mode for severe trauma in general hospitals and emphasizes the need to create a new temporary-sustainable team. It suggests developing an information consultation mode and enforcing the fine management to improve the quality and safety of the medical treatment. The management mode of a temporary-sustainable team will reduce the cost and improve the treatment efficiency. Overall, a temporary-sustainable team has significant advantages over a traditional multidisciplinary team for severe trauma treatment.
Female ; Humans ; Injury Severity Score ; Intersectoral Collaboration ; Male ; Multiple Trauma/therapy* ; Patient Care Team/organization & administration* ; Quality of Health Care ; Referral and Consultation ; Safety ; Trauma Severity Indices ; Traumatology/organization & administration* ; Treatment Outcome